{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:46:42Z","timestamp":1794718002530,"version":"4.9.1"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"9","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Implementation of primary human papillomavirus (HPV) testing has been slow in the United States perhaps because of concerns of decreased sensitivity compared with concurrent HPV and cytology testing (\u201ccotesting\u201d). We used the National Breast and Cervical Cancer Early Detection Program and the Kaiser Permanente of Northern California cohort to quantify potential trade-offs with primary HPV compared with cotesting in 4 US populations with differing precancer or cancer prevalence. In all settings, cotesting required more lab tests and more colposcopies compared with primary HPV testing. Additional cervical intraepithelial neoplasia grade 3 or cancer immediately detected from cotesting vs primary HPV decreased with decreasing population-average cervical intraepithelial neoplasia grade 3 or cancer prevalence from 71 per 100\u200a000 screened among never or rarely screened individuals in the National Breast and Cervical Cancer Early Detection Program (prevalence\u2009=\u20091212 per 100\u200a000) to 4 per 100\u200a000 screened among individuals with prior HPV-negative results in Kaiser Permanente of Northern California (prevalence\u2009=\u200986 per 100\u200a000). These data suggest that cotesting confer an unfavorable benefit-to-harm ratio over primary HPV testing.<\/jats:p>","DOI":"10.1093\/jnci\/djae117","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:50:06Z","timestamp":1717447806000},"page":"1525-1529","source":"Crossref","is-referenced-by-count":10,"title":["Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence"],"prefix":"10.1093","volume":"116","author":[{"given":"Shrutikona","family":"Das","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-0836","authenticated-orcid":false,"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8243-4686","authenticated-orcid":false,"given":"George F","family":"Sawaya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California San Francisco , San Francisco, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-4585","authenticated-orcid":false,"given":"Didem","family":"Egemen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-4669","authenticated-orcid":false,"given":"Alexander","family":"Locke","sequence":"additional","affiliation":[{"name":"Retired, Department of Obstetrics and Gynecology, The Permanente Medical Group , Sacramento, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5323-2249","authenticated-orcid":false,"given":"Walter","family":"Kinney","sequence":"additional","affiliation":[{"name":"Retired, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Permanente Medical Group , Sacramento, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-1515","authenticated-orcid":false,"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, The Permanente Medical Group Northern California Regional Laboratory , Berkeley, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-4331","authenticated-orcid":false,"given":"Li C","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"5","key":"2025052800062239200_djae117-B1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3322\/caac.21786","article-title":"Implementation in action: collaborating on the transition to primary HPV screening for cervical cancer in the United States","volume":"73","author":"Downs","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"2025052800062239200_djae117-B2","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","article-title":"The IARC perspective on cervical cancer screening","volume":"385","author":"Bouvard","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"2025052800062239200_djae117-B3","doi-asserted-by":"publisher","first-page":"366.e1","DOI":"10.1016\/j.ajog.2020.10.001","article-title":"Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017","volume":"224","author":"Saraiya","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2025052800062239200_djae117-B4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"5","key":"2025052800062239200_djae117-B5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/jnci\/djx225","article-title":"Relative performance of HPV and cytology components of cotesting in cervical screening","volume":"110","author":"Schiffman","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"2025052800062239200_djae117-B6","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/sim.7380","article-title":"Mixture models for undiagnosed prevalent disease and interval-censored incident disease: Applications to a cohort assembled from electronic health records","volume":"36","author":"Cheung","year":"2017","journal-title":"Stat Med"},{"issue":"2","key":"2025052800062239200_djae117-B7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025052800062239200_djae117-B8","author":"R Core Team"},{"issue":"suppl 5","key":"2025052800062239200_djae117-B9","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"2025052800062239200_djae117-B10","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s11606-016-3772-5","article-title":"Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical cancer screening for women above age 30 years","volume":"31","author":"Jin","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"7","key":"2025052800062239200_djae117-B11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamainternmed.2019.0299","article-title":"Estimated quality of life and economic outcomes associated with 12 cervical cancer screening strategies: a cost-effectiveness analysis","volume":"179","author":"Sawaya","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2025052800062239200_djae117-B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40258-014-0135-4","article-title":"Cost effectiveness of human papillomavirus-16\/18 genotyping in cervical cancer screening","volume":"13","author":"Huh","year":"2015","journal-title":"Appl Health Econ Health Policy"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djae117\/58342681\/djae117.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/9\/1525\/59032579\/djae117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/9\/1525\/59032579\/djae117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:06:28Z","timestamp":1748405188000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/116\/9\/1525\/7687058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,6,3]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djae117","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,6,3]]}}}